UNSPSC 51343501: Adefovir

This classification denotes a reverse transcriptase inhibitor with the molecular formula C8H12N5O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6GQP90I798, chemically known as phosphonic acid, ((2-(6-amino-9h-purin-9-yl)ethoxy)methyl)- but generally known as adefovir, which bears US NIH Compound Identifier 60172. Adefovir most often comes in dipivoxil and pivoxil forms. European Medicines Agency schedules Adefovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05264MIG.

UNSPSC 51343501 Adefovir, a Commodity code, nominally covers a single antiviral pharmaceutical product, yet the recent state and local opportunities tagged under this code show little alignment with adefovir itself. Instead, the two recorded opportunities solicit unrelated pharmaceutical supplies — Illinois Department of Public Health procured Doxycycline Hyclate and Ciprofloxacin Hydrochloride through a piggyback award to Chartwell Rx LLC, and Seminole County, Florida sought Naloxone and safe drug deactivation systems through a competitive bid. Neither opportunity involves adefovir or hepatitis B treatment. State and local procurement offices appear to use this code inconsistently or as a catch-all for general pharmaceutical supply, rather than for adefovir specifically. The issuing bodies span state health departments and county governments, both of which use piggyback contracts and competitive IFBs to source pharmaceuticals at scale. Neither opportunity applied set-aside designations, and both emphasized delivery logistics and compliance requirements such as E-Verify and drug-free workplace certification.

The code shows recent activity in Illinois and Florida, though the geographic spread cannot be characterized more broadly from only two recorded opportunities. The Illinois Department of Public Health awarded a $2,999,999.11 contract over 12 months with two renewal options through the MMCAP Infuse cooperative purchasing vehicle, with contact Mike Caceres at 217-577-7905. Seminole County's procurement was posted June 30, 2026 with a response deadline of July 26, 2023 — an apparent date error in the record — and required annual supplies of 1,900 units of Naloxone and 800 deactivation systems with quarterly deliveries to Sanford, Florida. This code does not currently offer a clear procurement signal for vendors focused on adefovir or related antiviral therapeutics.